| | 133099-04-4 Basic information More.. |
| Product Name: | Darifenacin | | Synonyms: | 2-(1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetaMide;UK 88525;UK88525;UK-88525;2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-dip;Darifenacin, >=98%;DARIFENACIN;2-[1-[2-(2,3-Dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-di(phenyl)acetamide | | CAS: | 133099-04-4 | | MF: | C28H30N2O2 | | MW: | 426.55 | | EINECS: | | | Mol File: | 133099-04-4.mol |  |
Use
Darifenacin is a novel muscarinic M3 selective antagonist for the once-daily oral treatment of urinary incontinence and overactive bladder. The majority of overactive bladder symptoms are thought to result from the overactivity of the detrusor muscle, which is primarily mediated by acetylcholine-induced stimulation of muscarinic M3 receptors in the bladder.
- Darifenacin
-
- US $200.00 / kg
- 2023-06-26
- CAS:133099-04-4
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 1000kg/Month
- Darifenacin
-
- US $100.00 / mg
- 2023-04-11
- CAS:133099-04-4
- Min. Order: 10mg
- Purity: 99%
- Supply Ability: 1000g
- Darifenacin
-
- US $25.99 / KG
- 2022-02-25
- CAS:133099-04-4
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100KG
|
|
133099-04-4
Recommend Suppliers |
|